Cargando…

Effects of Endocrine Disrupting Chemicals (EDCs) on Skeletal System Development: A Review

Introduction: Endocrine-disrupting chemicals (EDCs) are exogenous substances that alter endocrine function and cause adverse effects on an organism. EDC interference with the endocrine system leads to chronic autoimmune disorders, abnormal osteogenesis, infertility, and reproductive, neurological, c...

Descripción completa

Detalles Bibliográficos
Autores principales:	J, Chanemougavally, Thotakura, Balaji, M., Shruthy K, C. S., Janaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Endocrinology/Diabetes/Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612124/ https://www.ncbi.nlm.nih.gov/pubmed/37900387 http://dx.doi.org/10.7759/cureus.46109

Ejemplares similares

GPER as a Receptor for Endocrine-Disrupting Chemicals (EDCs)
por: Périan, Séverine, et al.
Publicado: (2020)

Exposure to endocrine-disrupting chemicals and anthropometric measures of obesity: a systematic review and meta-analysis
por: Ribeiro, Carolina Martins, et al.
Publicado: (2020)

Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients
por: Rachoń, Dominik
Publicado: (2016)

Advancements in the Management of Endocrine System Disorders and Arrhythmias: A Comprehensive Narrative Review
por: Kumari, Yogita, et al.
Publicado: (2023)

Combined Effects of Different Endocrine-Disrupting Chemicals (EDCs) on Prostate Gland
por: De Falco, Maria, et al.
Publicado: (2021)

Sarcopenia and Endocrine Ageing: Are They Related?
por: Gupta, Prishita, et al.
Publicado: (2022)

The effect of endocrine-disrupting chemicals on placental development
por: Yan, Yan, et al.
Publicado: (2023)

Endocrine Disrupting Chemicals: Effects on Endocrine Glands
por: Lauretta, Rosa, et al.
Publicado: (2019)

Unlocking India’s Potential in Managing Endocrine-Disrupting Chemicals (EDCs): Importance, Challenges, and Opportunities
por: Sharma, Brij Mohan, et al.
Publicado: (2022)

Metastatic Intracerebral Chondrosarcoma: Case Report and Literature Review of Endocrine Effects and Management Paradigms
por: Hussain, Namath S, et al.
Publicado: (2020)

Multiple Endocrine Neoplasia Type 1 Syndrome: A Case Report and Review of Literature
por: Boro, Hiya, et al.
Publicado: (2020)

Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?
por: Autrup, Herman, et al.
Publicado: (2020)

Exposure to endocrine disrupting chemicals (EDCs) and cardiometabolic indices during pregnancy: The HOME Study
por: Vuong, Ann M., et al.
Publicado: (2021)

Monitoring Endocrine Complications of Immunotherapy: A Screening Tool
por: Majety, Priyanka, et al.
Publicado: (2022)

The Hidden Threat: Endocrine Disruptors and Their Impact on Insulin Resistance
por: Dagar, Mehak, et al.
Publicado: (2023)

Adverse Endocrine-Related Effects of Pembrolizumab Precipitating Severe Hyponatremia
por: Baldawi, Muaamar B, et al.
Publicado: (2022)

Insulinoma Mimicking Psychiatric Illness: A Covert Endocrine Tumor
por: Aslam, Sidra, et al.
Publicado: (2023)

Granular Cell Pituitary Tumor in a Patient with Multiple Endocrine Neoplasia-1
por: Pendharkar, Arjun V, et al.
Publicado: (2019)

Late Pathomorphological Features of the Endocrine Pancreas in Patients With Type 2 Diabetes Mellitus
por: Tomova, Irina, et al.
Publicado: (2020)

Endocrine and Metabolic Manifestations of COVID-19 Patients Admitted to an Intensive Care Unit
por: Arora, Saurabh, et al.
Publicado: (2022)

Endocrine Abnormalities in Children With Traumatic Brain Injury at a Tertiary Care Center
por: Rao, Aaida, et al.
Publicado: (2023)

Assessing dose–response relationships for endocrine disrupting chemicals (EDCs): a focus on non-monotonicity
por: Zoeller, R Thomas, et al.
Publicado: (2015)

Growth Failure and Primary Amenorrhea: Endocrine Dysfunction as a Late Presentation of Crohn's Disease
por: Muthusamy, Suganthika D, et al.
Publicado: (2023)

Zollinger Ellison Syndrome Refractory to Medical Therapy in the Setting of Multiple Endocrine Neoplasia Type I
por: Martino, Brendan R, et al.
Publicado: (2022)

The Adipose Tissue at the Crosstalk Between EDCs and Cancer Development
por: Bokobza, Emma, et al.
Publicado: (2021)

Impact of endocrine disrupting chemicals and pharmaceuticals on Sertoli cell development and functions
por: Corpuz-Hilsabeck, Maia, et al.
Publicado: (2023)

Cushing’s Syndrome Due to a Functional Thymic Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 Syndrome
por: Asemota, Iriagbonse R, et al.
Publicado: (2021)

Multiple Endocrine Neoplasia Type 1 (MEN1) Presenting as an Invasive Macroprolactinoma Complicated by Acute Bacterial Meningitis
por: Bandaru, Sindhura, et al.
Publicado: (2021)

Clinical Spectrum and Causes of Delayed Puberty Among Patients Presenting to the Endocrine Clinic at Jinnah Postgraduate Medical Centre
por: Zahra, Fatima, et al.
Publicado: (2022)

The Future of Cross-Continental Telemedicine in the Management of Complicated Endocrine Patients and Its Suitability Based on a Case Report
por: Khan, Zahid, et al.
Publicado: (2022)

Imaging and Diagnostic Challenges in a Patient With Refractory Hypoglycemia Caused by Insulinomas Related to Multiple Endocrine Neoplasia Type 1
por: Nance, Michael E, et al.
Publicado: (2020)

Primary Hypothyroidism Unleashing Severe Pericardial Effusion: Lessons Learnt From an Atypical Presentation of a Common Endocrine Condition
por: Kapoor, Ashutosh, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor-Induced Endocrine Adverse Events in Cancer Patients at a Tertiary Care Center in Saudi Arabia
por: Alqahtani, Ali, et al.
Publicado: (2023)

Skeletal Fluorosis: An Unusual Manifestation of Computer Cleaner Inhalant Abuse
por: Liane, Billy-Joe, et al.
Publicado: (2020)

Skeletal Fluorosis in a Patient With Computer Cleaner Inhalant Abuse
por: Chen, Evan, et al.
Publicado: (2023)

Endocrine-Disrupting Chemicals (EDCs): In Vitro Mechanism of Estrogenic Activation and Differential Effects on ER Target Genes
por: Li, Yin, et al.
Publicado: (2013)

Endocrine-Disrupting Chemicals’ (EDCs) Effects on Tumour Microenvironment and Cancer Progression: Emerging Contribution of RACK1
por: Buoso, Erica, et al.
Publicado: (2020)

Do macrophages play a role in the adverse effects of endocrine disrupting chemicals (EDCs) on testicular functions?
por: Cui, Haoyi, et al.
Publicado: (2023)

Euglycemic Diabetic Ketoacidosis in a Patient With Urinary Tract Infection
por: Patlolla, Sridhar Reddy, et al.
Publicado: (2023)

Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease
por: Papalou, Olga, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7ns98jtkaiio3vc6r2na5r8n8s